Cargando…

A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study

BACKGROUND: There is a risk of drug sorption into an intravenous administration set composed of polyvinyl chloride (PVC), polyurethane (PU), or polyolefin (PO). This has implications on the dose of the active ingredient the patient receives, and thus therapeutic success. This study aimed to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Choon Ok, Song, Jeongyun, Min, Ji Young, Park, Su Jung, Lee, Hye Mi, Byon, Hyo-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851736/
https://www.ncbi.nlm.nih.gov/pubmed/29489681
http://dx.doi.org/10.1097/MD.0000000000009829
_version_ 1783306445817643008
author Kim, Choon Ok
Song, Jeongyun
Min, Ji Young
Park, Su Jung
Lee, Hye Mi
Byon, Hyo-Jin
author_facet Kim, Choon Ok
Song, Jeongyun
Min, Ji Young
Park, Su Jung
Lee, Hye Mi
Byon, Hyo-Jin
author_sort Kim, Choon Ok
collection PubMed
description BACKGROUND: There is a risk of drug sorption into an intravenous administration set composed of polyvinyl chloride (PVC), polyurethane (PU), or polyolefin (PO). This has implications on the dose of the active ingredient the patient receives, and thus therapeutic success. This study aimed to determine the plasma concentration of nitroglycerin and the effect of nitroglycerin on patients based on the composition of the administration set. METHODS: Using a randomized, open-labeled, 3 × 3 crossover method, 9 volunteers were assigned to 3 groups. In period I, nitroglycerin (100 μg/mL) was infused via a PVC- (group A), PU- (group B), or PO-based (group C) administration set. In period II, PU- (group A), PO- (group B), and PVC-based (group C) administration sets were used, and in period III, PO- (group A), PVC- (group B), and PU-based (group C) administration sets were used. The rate of drug administration in all periods was 12 mL/hour for 30 minutes using an infusion pump. Blood samples were collected, and the plasma concentrations of nitroglycerin were analyzed using validated high-performance liquid chromatography coupled with tandem mass spectrometry. Blood pressure was determined using a sphygmomanometer applied to the other upper arm at an interval of 5 minutes. RESULTS: We observed that the mean plasma concentration of nitroglycerin over time when administered using a PO-based tube was higher than that when using a PU- or PVC-based tube. When the percent change of the mean arterial pressure from baseline at each time point was compared among groups, there were statistically significant differences between PU and PO or PVC at most points during nitroglycerin infusion. CONCLUSION: Our results showed higher nitroglycerin plasma concentration and lower arterial pressure when a PO-based administration set was used than when a PVC- or PU-based administration set was used. PO-based administration sets may be more appropriate for nitroglycerin administration compared to those composed of PVC or PU.
format Online
Article
Text
id pubmed-5851736
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-58517362018-03-21 A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study Kim, Choon Ok Song, Jeongyun Min, Ji Young Park, Su Jung Lee, Hye Mi Byon, Hyo-Jin Medicine (Baltimore) 4200 BACKGROUND: There is a risk of drug sorption into an intravenous administration set composed of polyvinyl chloride (PVC), polyurethane (PU), or polyolefin (PO). This has implications on the dose of the active ingredient the patient receives, and thus therapeutic success. This study aimed to determine the plasma concentration of nitroglycerin and the effect of nitroglycerin on patients based on the composition of the administration set. METHODS: Using a randomized, open-labeled, 3 × 3 crossover method, 9 volunteers were assigned to 3 groups. In period I, nitroglycerin (100 μg/mL) was infused via a PVC- (group A), PU- (group B), or PO-based (group C) administration set. In period II, PU- (group A), PO- (group B), and PVC-based (group C) administration sets were used, and in period III, PO- (group A), PVC- (group B), and PU-based (group C) administration sets were used. The rate of drug administration in all periods was 12 mL/hour for 30 minutes using an infusion pump. Blood samples were collected, and the plasma concentrations of nitroglycerin were analyzed using validated high-performance liquid chromatography coupled with tandem mass spectrometry. Blood pressure was determined using a sphygmomanometer applied to the other upper arm at an interval of 5 minutes. RESULTS: We observed that the mean plasma concentration of nitroglycerin over time when administered using a PO-based tube was higher than that when using a PU- or PVC-based tube. When the percent change of the mean arterial pressure from baseline at each time point was compared among groups, there were statistically significant differences between PU and PO or PVC at most points during nitroglycerin infusion. CONCLUSION: Our results showed higher nitroglycerin plasma concentration and lower arterial pressure when a PO-based administration set was used than when a PVC- or PU-based administration set was used. PO-based administration sets may be more appropriate for nitroglycerin administration compared to those composed of PVC or PU. Wolters Kluwer Health 2018-03-02 /pmc/articles/PMC5851736/ /pubmed/29489681 http://dx.doi.org/10.1097/MD.0000000000009829 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4200
Kim, Choon Ok
Song, Jeongyun
Min, Ji Young
Park, Su Jung
Lee, Hye Mi
Byon, Hyo-Jin
A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study
title A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study
title_full A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study
title_fullStr A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study
title_full_unstemmed A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study
title_short A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study
title_sort comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: a preliminary study
topic 4200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851736/
https://www.ncbi.nlm.nih.gov/pubmed/29489681
http://dx.doi.org/10.1097/MD.0000000000009829
work_keys_str_mv AT kimchoonok acomparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT songjeongyun acomparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT minjiyoung acomparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT parksujung acomparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT leehyemi acomparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT byonhyojin acomparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT kimchoonok comparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT songjeongyun comparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT minjiyoung comparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT parksujung comparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT leehyemi comparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy
AT byonhyojin comparisonofthepharmacokineticandpharmacodynamicpropertiesofnitroglycerinaccordingtothecompositionoftheadministrationsetapreliminarystudy